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Dr Philip Goodney (Lebanon, NH). I think this is an elegant
investigation into the pathophysiology underlying higher stroke rates
following carotid stenting in patients of older age groups. I think these
findings are intriguing, and I have several questions toward this end.
First, I have a technical question about the imaging results.
Was the decrease in cerebral reserve always ipsilateral to the carotid
stenosis or occlusion? How often did it tend to cross over to the
other hemisphere? And did that differ by stenosis or occlusion?
My second question focuses on your hypothesis that carotid
stenosis may cause a decrease in cerebral reserve, as detected by
your imaging methods. One would anticipate, however, that pa-didn’t find that. I wonder if that’s a sample size issue or if you had
some insight into that.
My third question pertains to the rates of statin and antiplate-
let therapy in this population in your study. As you pointed out,
patients with coronary disease and even those patients with symp-
tomatic carotid disease were on fairly low rates of statin and
antiplatelet therapy. I know this is a population that’s drawn over a
10-year period, so I wonder if you found that those rates increased
over time.
And just lastly, you mentioned that barriers exist to the use of
this technology in the US. How are you and your colleagues
dealing with these barriers in Pittsburgh?
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Volume 52, Number 3 Chaer et al 575Dr Rabih Chaer (Pittsburgh, Pa). The laterality of abnormal
blood flow scans was equally distributed as compared with the site
of the stenosis. Laterality of an abnormal xenon scan may not be
relevant in this situation since emboli that are generated during
carotid angioplasty and stenting can be bilateral as they can origi-
nate from the arch.
Regarding the number of patients that were treated with
statins or antiplatelets, this is clearly one of the limitations of a
retrospective analysis. Perhaps this wasn’t common therapy back
then, but it certainly does not reflect current practice.
Regarding the availability of the xenon study, xenon’s privi-
leged status as a contrast agent in the United States was revoked by
the FDA in 2001. It is currently readily available overseas but not
in the US, although reapproval may be expected in the future.
Regarding your question on intracranial stenoses, this was
specifically analyzed because one would expect, as you mentioned,
that it will have a significant effect on reserve. I do suspect that the
lack of significant association between reserve and intracranial
stenosis is related to the small sample size of patients with intracra-
nial stenosis, as pointed out.
Dr James Black (Baltimore, Md). I’ve been thinking about
this subject a lot lately because I had a patient just a couple weeks
ago who had a watershed stroke after what I thought was a pretty
uneventful carotid procedure. As a matter of fact, over the past 5
years, three of the patients who have had strokes in my hands with
carotid surgery, two of the three were called watershed by subse-
quent imaging. The imaging that showed that was an MRI with
perfusion and diffusion-weighted images. And could you just
enlighten us as to what the overlap could be, with the available
study we have, to determine watershed vs embolic, that is MRI,
and what this technology is, so we could sort of compare apples
and apples?
Then the other question, of course, is, do you have any
long-term data about the patients who had poor cerebral reserve in
terms of their overall survival, or could that be obtainable in the set
that you have?
Dr Chaer. There have been a few studies comparing diffusion
MRI with xenon CT. There are multiple modalities that one could
use for the physiologic imaging of the brain. Xenon CT scanning
seems to always pan out as the most accurate and preferredmodality; although diffusionMRI comes close, but it is not equally
accurate.
Xenon CT remains frequently utilized outside the US as the
pre- and postoperative imaging modality of choice in dedicated
centers performing intracranial bypass surgery. I don’t have long-
term follow-up on those patients. I do suspect that perhaps many
of them are deceased, since the data collection stopped in 2001.
Dr Wei Zhou (Palo Alto, Calif). A total of 47% of your
patient cohort had a history of stroke. Did any of the patients
undergo revascularization procedures? If so, was there any im-
provement in cerebral blood flow on the xenon CT?
Dr Chaer. The etiology of stroke in this series was multifac-
torial and included embolic sources as well as aneurysm rupture
and bleeding. Those patients who had revascularization proce-
dures for severe carotid stenosis did not routinely get a xenon serial
blood flow study as a follow-up.
Dr Vance Smith (Muskegon, Mich). A number of years ago,
there were several papers on CO2 reactivity stress testing with
transcranial doppler that showed a correlation with hemodynami-
cally significant stenosis in the cervical carotid and also a correlation
with stroke in the untreated patients. And particularly in patients
who had an occlusion, ipsilateral or contralateral, there was an
increased risk of stroke if they had decreased cerebral vascular
reserve on TCD CO2 reactivity stress testing, which is pretty easy
to do, just having them rebreathe in a gallon ziplock baggie. It
appeared beneficial to anticoagulate some occlusion patients with
reduced cerebrovascular reserve. I wonder if TCD CO2 reactivity
stress testing was something of interest to you or if you looked into
it. I found it useful in my practice evaluating the significance of
carotid stenosis, and I think it’s been useful selecting some patients
with carotid occlusions having a higher stroke rate and benefiting
from anticoagulation.
Dr Chaer. A recent study has compared xenon CT to TCD
imaging. Xenon CT imaging provided better brain physiologic
imaging. You do raise a significant question, however, as we had
demonstrated in a previous study with xenon CT that the loss of
cerebral reactivity in symptomatic patients with carotid occlusion
or severe 70% carotid stenosis was predictive of cerebral infarc-
tion.
